Han Xiaowei, Ashraf Muhammad, Tipparaju Srinivas M, Xuan Wanling
Department of Pharmaceutical Sciences, USF Health Taneja College of Pharmacy, University of South Florida, Tampa, FL, United States.
Front Aging Neurosci. 2023 Jul 27;15:1221653. doi: 10.3389/fnagi.2023.1221653. eCollection 2023.
Sarcopenia is an age-related, involuntary loss of skeletal muscle mass and strength. Alzheimer's disease (AD) is the most common cause of dementia in elderly adults. To date, no effective cures for sarcopenia and AD are available. Physical and cognitive impairments are two major causes of disability in the elderly population, which severely decrease their quality of life and increase their economic burden. Clinically, sarcopenia is strongly associated with AD. However, the underlying factors for this association remain unknown. Mechanistic studies on musclebrain crosstalk during cognitive impairment might shed light on new insights and novel therapeutic approaches for combating cognitive decline and AD. In this review, we summarize the latest studies emphasizing the association between sarcopenia and cognitive impairment. The underlying mechanisms involved in musclebrain crosstalk and the potential implications of such crosstalk are discussed. Finally, future directions for drug development to improve age-related cognitive impairment and AD-related cognitive dysfunction are also explored.
肌肉减少症是一种与年龄相关的骨骼肌质量和力量的非自愿性丧失。阿尔茨海默病(AD)是老年人痴呆最常见的病因。迄今为止,尚无针对肌肉减少症和AD的有效治愈方法。身体和认知障碍是老年人群残疾的两个主要原因,这严重降低了他们的生活质量并增加了经济负担。临床上,肌肉减少症与AD密切相关。然而,这种关联的潜在因素仍然未知。关于认知障碍期间肌肉与大脑相互作用的机制研究可能会为对抗认知衰退和AD带来新的见解和新颖的治疗方法。在这篇综述中,我们总结了强调肌肉减少症与认知障碍之间关联的最新研究。讨论了肌肉与大脑相互作用所涉及的潜在机制以及这种相互作用的潜在影响。最后,还探讨了改善与年龄相关的认知障碍和AD相关认知功能障碍的药物开发的未来方向。